Trial intelligence / Profile preview

Phase 2 DAY101 in pediatric RAF-altered recurrent or progressive low-grade glioma and advanced solid tumors

NL-OMON52145Phase 2Recruiting

Sponsor

Day One Biopharmaceuticals

Start

Nov 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1